12 Medical secures $45M Series B funding for neuromodulation therapy for obstructive sleep apnea.

12 Medical secures $45M Series B funding led by Omega Funds and Intuitive Ventures to advance neuromodulation therapy for obstructive sleep apnea, aiding 425 million people globally. The funds will be used for clinical research and product development, focusing on simplifying therapy, expanding access, and addressing patient compliance issues. Founded in 2017, the company aims to improve treatment outcomes and collaborate with leading partners for technology advancement.

August 21, 2024
7 Articles

Further Reading